about
Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cellsHuman and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cellsTargeting innate immunity for neurodegenerative disorders of the central nervous systemCell-based therapies of liver diseases: age-related challengesAllogenic banking of dental pulp stem cells for innovative therapeuticsSetting Up a Haplobank: Issues and SolutionsPluripotent stem cells in research and treatment of hemoglobinopathiesThe potential for immunogenicity of autologous induced pluripotent stem cell-derived therapiesMyocardial cell sheet therapy and cardiac functionInterspecies chimera between primate embryonic stem cells and mouse embryos: monkey ESCs engraft into mouse embryos, but not post-implantation fetuses.Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cellsCell reprogramming and neuronal differentiation applied to neurodegenerative diseases: Focus on Parkinson's diseasePresent and future challenges of induced pluripotent stem cellsBanking on iPSC--is it doable and is it worthwhileA more efficient method to generate integration-free human iPS cellsMHC-matched induced pluripotent stem cells can attenuate cellular and humoral immune responses but are still susceptible to innate immunity in pigsAdvances and prospect of nanotechnology in stem cells.Immunological considerations for embryonic and induced pluripotent stem cell banking.Establishment and characterization of baboon embryonic stem cell lines: an Old World Primate model for regeneration and transplantation researchRisk factors in the development of stem cell therapyThe business of exploiting induced pluripotent stem cells.Amnion-derived stem cells: in quest of clinical applications.Human amniotic epithelial cells are reprogrammed more efficiently by induced pluripotency than adult fibroblasts.Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesCellular models and therapies for age-related macular degeneration.Development of histocompatible primate-induced pluripotent stem cells for neural transplantationHurdles to clinical translation of human induced pluripotent stem cellsPluripotent stem cell applications for regenerative medicineReprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells.Tissue Engineering and Regenerative Medicine 2015: A Year in ReviewModulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantationUse of a Human Artificial Chromosome for Delivering Trophic Factors in a Rodent Model of Amyotrophic Lateral Sclerosis.Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent.Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases.Assessing the value of autologous and allogeneic cells for regenerative medicine.Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.Generation and genetic modification of induced pluripotent stem cells.Elimination of blood group antigens: hope and reality.How to cross immunogenetic hurdles to human embryonic stem cell transplantation.
P2860
Q21560823-9D7C4BD1-5E9E-4465-AFAC-92B7D86FF964Q24624032-97CFD9F3-D369-4AD7-91D1-23C4D17FAB38Q26744219-06528340-BE7B-495E-8490-E7C5ABB75652Q26776328-2666FD24-A190-4C9E-BAC2-55F9EC846E98Q26795542-177D5E5E-6061-4D08-B5B7-9C78341D48C7Q26801583-4EB5324A-FA4E-44AC-BD36-A4DC28334831Q26825713-5B877768-2C87-42BB-8624-4C51DD92D762Q26851666-0DE99D27-420B-4F0E-94B9-10AA0CA5E324Q26999246-DF990CC0-6344-471C-8CF0-3535C012AE5AQ27303862-769F2D4F-D939-4791-95FD-9F14C3E68F43Q27333621-E79E4AFE-59E2-40D0-8BD5-D30E06F71996Q28080770-85EAB529-27AA-400B-9C00-1D13D94A718AQ28082747-2F886554-05ED-4DAB-BCDE-C32968A6801DQ28254023-196301A0-FC1A-4BD4-A607-968E4EE5A6D6Q29615748-442D9E6B-8EFF-4138-82E4-BC8090A84557Q33753368-8AD70CA7-B4E8-45BD-9FD1-0153C1B28525Q33948616-769E711E-8B28-4FE3-AEB2-60116E284C24Q34197332-BD86D568-8E77-43BC-B6BA-B91449B34D03Q34280009-09815599-FD06-4024-B1D3-19C54A844A58Q34761224-2E176E9A-94A6-4D10-A8AF-051792A6E96AQ35088543-A8077551-BF7B-473B-9D31-19F9617E6945Q35155196-5240D84E-B695-4FBB-9DDE-31DDD8761879Q35180516-89DB8255-0EA6-4678-9F3B-E374907970EBQ35200156-D253AE51-A8A6-467D-B419-90641F32BEDBQ35558042-41B0AACE-1C5F-41A2-8CCD-5123F155D49AQ35924439-FDD7D5DB-C57E-44DC-916E-F4D4F4FF66BAQ36040255-19538A7D-65DE-45BF-8A0C-98B0C592FFEEQ36255019-299A2299-538D-4EBF-BC4B-A2E1563C6711Q36448423-6DB4F26A-1003-4152-8EDA-E8EFE1FA0023Q36756232-A0952668-53BA-4D83-9EBF-19FC3244B29CQ36879075-510126B0-02C5-404D-AF0D-5E79CF9A6994Q36939729-ED676C60-7A8D-4E20-8523-1040D82266DCQ37358913-771A302A-D6EC-4858-A6BA-A106A97934F8Q37598915-C6067865-8B82-4372-BAF4-8B29D11650E8Q37624953-C0C85CF4-7A79-4D16-B88A-7D76D2AE370EQ37630522-3AE7E17B-BAF1-4A70-862D-6431FBBB8C36Q37756278-C8E156C0-F950-4C9F-841F-7F8556234B57Q37763190-A86939B6-2B66-4A1D-81DE-B0FCACD991C1Q37826438-61B4DB30-E1CC-48FB-A4C9-2F4A2A35DD88Q37860986-297C7DB8-0AD9-4A57-9E80-B35B01F895AC
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
HLA-haplotype banking and iPS cells.
@en
HLA-haplotype banking and iPS cells.
@nl
type
label
HLA-haplotype banking and iPS cells.
@en
HLA-haplotype banking and iPS cells.
@nl
prefLabel
HLA-haplotype banking and iPS cells.
@en
HLA-haplotype banking and iPS cells.
@nl
P2093
P356
P1433
P1476
HLA-haplotype banking and iPS cells.
@en
P2093
Fumiaki Nakajima
Katsushi Tokunaga
Norio Nakatsuji
P2888
P304
P356
10.1038/NBT0708-739
P577
2008-07-01T00:00:00Z